Deborah Dillon
Harvard University(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, Cancer Cells and Metastasis, Breast Cancer Treatment Studies, Neutropenia and Cancer Infections
Most-Cited Works
- → Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer(2016)621 cited
- → Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors(2016)478 cited
- → A pathology foundation model for cancer diagnosis and prognosis prediction(2024)346 cited
- → Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer(2019)277 cited
- → Whole Genome Analysis of Genetic Alterations in Small DNA Samples Using Hyperbranched Strand Displacement Amplification and Array–CGH(2003)265 cited
- → Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages(2020)265 cited
- → Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer(2020)246 cited
- → Application of desorption electrospray ionization mass spectrometry imaging in breast cancer margin analysis(2014)242 cited
- → Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition(2017)239 cited
- → STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer(2022)235 cited